Series A - Kojin Therapeutics
Investment Firm
Overview
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
Announced Date
Jun 09, 2021
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Polaris Partners
Polaris Partners is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.
Cathay Capital
Cathay Capital is a early_stage_venture and seed firm.
Newpath Management
Newpath Management is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.
Participant Investors
7
Round Details and Background
Kojin Therapeutics raised $60000000 on 2021-06-09 in Series A
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 09, 2021 |  Series A - Kojin Therapeutics | 8 | - | 60.0M |
Recent Activity
There is no recent news or activity for this profile.